SIM
IMUX icon

Spark Investment Management’s Immunic IMUX Stock Holding History

Spark Investment Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-148
Closed -$1.47M – 693
2015
Q1 		$1.47M Buy
148
+71
+92% +$653K 0.21% 160
2014
Q4 		$762K Buy
77
+5
+7% +$38.5K 0.13% 233
2014
Q3 		$575K Sell
72
-10
-12% -$94.4K 0.09% 310
2014
Q2 		$879K Buy
+82
New +$575K 0.13% 234

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Spark Investment Management's IMUX Position: Q2 2015 in Review

Spark Investment Management sold out of Immunic (IMUX) in Q2 2015, closing a stake of 148 shares — an estimated $1.47M sold.

Spark Investment Management first reported a position in IMUX in Q2 2014 and held it in 4 quarters. The position peaked at $1.47M in Q1 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q2 2015.

  • Spark Investment Management reported no remaining Immunic position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 148 Immunic shares in Q2 2015, an estimated $1.47M.
  • Spark Investment Management first reported a position in Immunic in Q2 2014 and held it in 4 quarters.
  • Spark Investment Management's Immunic position peaked at $1.47M in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Immunic as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.